Key Details
Annual ROE
7.31%Beta
-Events Calendar
Next earnings date:
N/ARecent quarterly earnings:
Mar 15, 2023Recent annual earnings:
Mar 15, 2023Next ex-dividend date:
N/ARecent ex-dividend date:
N/ANext split:
N/ARecent split:
Dec 31, 2014Analyst ratings
Recent major analysts updates
09 Dec '21 Oppenheimer
Outperform28 Sept '18 Cantor Fitzgerald
Overweight12 June '18 Cantor Fitzgerald
Overweight30 Nov '12 Mizuho
Neutral01 Nov '12 Cantor Fitzgerald
01 Nov '12 B. Riley Securities
Neutral31 Oct '12 Evercore ISI Group
Equal-Weight08 Aug '12 Wedbush
Neutral29 June '12 Wedbush
Neutral18 May '12 Stephens & Co.
Equal-WeightScreeners with OPNT included
No data
Market Data
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Dividend
Opiant Pharmaceuticals doesn't have historical dividend data
Profitability
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Efficiency
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Valuation
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Liquidity
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Cash Flow
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Institutional Ownership
Similar stocks
FAQ
- What is the primary business of Opiant Pharmaceuticals?
- What is the ticker symbol for Opiant Pharmaceuticals?
- Does Opiant Pharmaceuticals pay dividends?
- What sector is Opiant Pharmaceuticals in?
- What industry is Opiant Pharmaceuticals in?
- What country is Opiant Pharmaceuticals based in?
- When did Opiant Pharmaceuticals go public?
- Is Opiant Pharmaceuticals in the S&P 500?
- Is Opiant Pharmaceuticals in the NASDAQ 100?
- Is Opiant Pharmaceuticals in the Dow Jones?
- When was Opiant Pharmaceuticals's last earnings report?
- When does Opiant Pharmaceuticals report earnings?
- Should I buy Opiant Pharmaceuticals stock now?
What is the primary business of Opiant Pharmaceuticals?
Opiant Pharmaceuticals, Inc., a specialty pharmaceutical company, develops medicines for addictions and drug overdose. The company offers NARCAN nasal spray, a treatment to reverse opioid overdoses. Its pipeline of product candidates includes medicines for the treatment for opioid overdose reversal; alcohol use disorders; acute cannabinoid overdose; and opioid use disorders. The company was formerly known as Lightlake Therapeutics Inc. and changed its name to Opiant Pharmaceuticals, Inc. in January 2016. Opiant Pharmaceuticals, Inc. was incorporated in 2005 and is headquartered in Santa Monica, California.
What is the ticker symbol for Opiant Pharmaceuticals?
The ticker symbol for Opiant Pharmaceuticals is NASDAQ:OPNT
Does Opiant Pharmaceuticals pay dividends?
No, Opiant Pharmaceuticals does not pay dividends
What sector is Opiant Pharmaceuticals in?
Opiant Pharmaceuticals is in the Healthcare sector
What industry is Opiant Pharmaceuticals in?
Opiant Pharmaceuticals is in the Biotechnology industry
What country is Opiant Pharmaceuticals based in?
Opiant Pharmaceuticals is headquartered in United States
When did Opiant Pharmaceuticals go public?
Opiant Pharmaceuticals's initial public offering (IPO) was on 04 June 2007
Is Opiant Pharmaceuticals in the S&P 500?
No, Opiant Pharmaceuticals is not included in the S&P 500 index
Is Opiant Pharmaceuticals in the NASDAQ 100?
No, Opiant Pharmaceuticals is not included in the NASDAQ 100 index
Is Opiant Pharmaceuticals in the Dow Jones?
No, Opiant Pharmaceuticals is not included in the Dow Jones index
When was Opiant Pharmaceuticals's last earnings report?
Opiant Pharmaceuticals's most recent earnings report was on 15 March 2023
When does Opiant Pharmaceuticals report earnings?
The date for Opiant Pharmaceuticals's next earnings report has not been announced yet
Should I buy Opiant Pharmaceuticals stock now?
As of today, analysts generally recommend a 'Hold' rating. However, it's important to do your own research and consider your financial situation before making any investment decisions